Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma
This study has been completed.
Sponsor:
University of Wuerzburg
Information provided by:
University of Wuerzburg
ClinicalTrials.gov Identifier:
NCT00306813
First received: March 15, 2006
Last updated: August 3, 2009
Last verified: March 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | December 2008 |
| Estimated Primary Completion Date: | No date given |
No publications provided by University of Wuerzburg
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):